7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG, PHARMAZEUTISCHE PRÄPARATE, DIE DIESE 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENE ENTHALTEN SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0920441B1
公开(公告)日:2003-01-29
US5986115A
申请人:——
公开号:US5986115A
公开(公告)日:1999-11-16
US6271403B1
申请人:——
公开号:US6271403B1
公开(公告)日:2001-08-07
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production,
申请人:Schering AG
公开号:US05866560A1
公开(公告)日:1999-02-02
This invention describes new, substituted 7.alpha.-(.xi.-aminoalkyl)-estratrienes of general formula I ##STR1## in which side chain SK is a radical of partial formula ##STR2## as well as their physiologically compatible addition salts with organic and inorganic acids. The new compounds represent compounds with very strong antiestrogenic action. The compounds according to the invention are, on the one hand, pure antiestrogens, or, on the other hand, antiestrogens with estrogenic partial action. Based on this spectrum of action, the new compounds are highly suitable for the production of pharmaceutical agents for tumor therapy and hormone replacement treatment.